, Singapore
202 views

A look into SG's biomedical production as world transitions to COVID normalcy

The sector logged a second month of decline.

As most countries treat COVID to be settling into endemic, Singapore's biomedical manufacturing cluster kept declining, registering 1.1% decrease year-on-year (YoY) in April 2022, which marked its second month of decline.

This is according to the banking firm, UOB, which reacted to the Economic Development Board’s report on the manufacturing sector.

It said the biomedical cluster was affected by the lower output of pharmaceuticals with 11.3% decline YoY but stronger production of medical technology cushioned the downtick, UOB Chief Economist & Head of Treasury Research & Strategy, Global Treasury, Selena Ling said.

Despite this, UOB is still optimistic that the COVID-19 normalcy will produce a positive impact on Singapore’s manufacturing sector.

It added that the manufacturing growth will stay at 4% this year as the transport engineering sector showed encouraging results on the back of easing international border restrictions. 

READ MORE: Transport engineering sector keeps manufacturing growth outlook at 4% 

"Even if manufacturing momentum tapers in the coming months, there may be a slight upside risk to our full-year 2022 manufacturing growth forecast of 3.8% YoY," Ling said with caution because of the China slowdown story in the second quarter, the global supply chain disruptions, and the aggressive monetary policy tightening by major central banks.

Join Singapore Business Review community

Follow the link s for more news on

Join Singapore Business Review community
A NOTE FROM SINGAPORE BUSINESS REVIEW

If you've been wondering whether SBR could work for your company — yes, probably.

A lot of the companies we partner with started as readers. They'd been following our coverage for a while, saw their own customers and competitors in it, and eventually asked the obvious question: could we do something with you? The answer is usually yes. The shape of it depends on what you're trying to do.


The options are broader than most people assume — thought leadership articles, sponsored content, industry summits across Southeast Asia, regional awards programmes, podcasts, and media placements in print and digital. Some partners use one channel; most use a mix. We figure out the right combination by starting with your brief, not with our rate card.


So if the question has been on your mind, here's the easy way to ask it.

We'll tell you honestly whether we can help, and how. It's a better use of everyone's time.

Top News

Singapore targets $645m fund for SEA climate projects
The programme will also feature a data platform and a market development facility.
iWOW swings to $700,000 loss in H1 2027
Datacomm revenue fell 41%, whilst wireless engineering declined 35%.